Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)
CAPS Rating:
A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options.
RSS Headlines
Fool UK
Recs
Even if not taken over by Big Pharma, this is one worth paying attention to.